Posts Tagged: "Medimmune v. Genentech"

The dispute arose from a Mexican patent infringement suit between Stellar and two of Allied’s Mexican distributors. Allied manufactures the products accused of infringement in the United States, which are then sold in Mexico by Allied’s Mexican’s distributors. Allied sells the same product in the United States under a different name… For a patent dispute to be an actual controversy, the courts look at affirmative actions taken by the patentee, communication between the parties, the relevant litigation history, and the relationship between any foreign suits and the US parties and patents. Assertion of a foreign patent against foreign distributors does not per se create an actual controversy, for declaratory judgment, regarding infringement of a corresponding US patent by a US manufacturer.

The district court determined that it lacked subject matter jurisdiction because Preston’s state-law claims did not arise under federal law and Nagel’s patent counterclaims did not present a justiciable case or controversy under Article III because the patent dispute was not imminent. Therefore, the district court remanded the case and Nagel timely appealed… The AIA and its strengthening of federal court jurisdiction over patent claims did nothing to override the rule that a district court decision to remand a case to state court is not appealable under §1447(d).